SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

KOPRAN

BSE: 524280 29 Jun 2025
Healthcare
₹ 175.85
Kopran Ltd., specializes in Pharmaceuticals within the Healthcare sector.

KOPRAN - Share Price & Details

Market Cap
₹902.0
High /Low
370.0 / 155.0
Stock P/E
23.4
Book Value
₹107.0
Dividend Yield
1.61
ROCE
9.75
ROE
₹7.64
Face Value
10.0
PEG Ratio
1.89
EVEBITDA
₹13.3
Debt
148
CMP / FCF
-62.6
Debt to equity
₹0.29
NP Ann
38.6
High price all time
370.0
Piotroski score
₹3.0
Graham Number
139.0
No. Eq. Shares
4.82
Net CF
₹11.4
Net profit
38.6
Price to book value
1.74
Interest Coverage
₹6.56
Low price all time
6.0
Industry PE
32.0
Reserves
₹470
Free Cash Flow
₹-17.0

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
KOPRAN LTD.778.5285.99759.351.78902.023.4
Bharat Parenterals LimitedNANANANA77729.4
Shree Ganesh Remedies LimitedNANANANA77733.7

Peer Comparison Chart


About KOPRAN

Kopran Ltd.,, with Security Code 524280, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Has Kopran declared dividend?

(07 Jun 2025)
Kopran Ltd has declared a 30% dividend, amounting to ₹3 per share, with an ex-date of September 2, 2024. Despite recent price declines,...
Read more →

Madhusudan Kela’s favourite stocks trading at over 50% discount – Time to buy?

(31 May 2025)
Two of Ace investor and one of India's Warren Buffett, Madhusudan Kela's favourite stocks now trade at discounts of over 50%.
Read more →

Kopran Ltd recommends dividend of Rs. 3

(16 May 2025)
The Board of Directors of Kopran Ltd has recommended dividend of Rs. 3.00 per Equity Share of F.V Rs.10 (30%) for the financial year ended...
Read more →

Kopran Reports Declining Profits and Rising Interest Expenses in March 2025 Results

(16 May 2025)
Kopran has announced its financial results for the quarter ending March 2025, revealing a decline in Profit Before Tax at Rs 10.45 crore and...
Read more →

Kopran consolidated net profit declines 48.01% in the March 2025 quarter

(14 May 2025)
Sales decline 7.37% to Rs 172.36 crore. Net profit of Kopran declined 48.01% to Rs 9.68 crore in the quarter ended March 2025 as against Rs...
Read more →

Kopran Faces Bearish Shift Amid Declining Sales and Market Sentiment Concerns

(10 May 2025)
Kopran, a microcap in the Pharmaceuticals & Drugs sector, has experienced a recent evaluation adjustment, indicating a shift in market sentiment.
Read more →